KPRX · Categories · Form 4

KPRX - SEC Form 4 insider transactions

Kiora Pharmaceuticals Inc. (KPRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for KPRX

• 68d
  SEC Form 4 filed by Tosca Melissa

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 68d
  SEC Form 4 filed by Daniels Eric Joseph

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 68d
  SEC Form 4 filed by Strem Brian M.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 91d
  SEC Form 4 filed by Kiora Pharmaceuticals Inc.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 91d
  SEC Form 4 filed by Kiora Pharmaceuticals Inc.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 91d
  President and CEO Strem Brian M. was granted 16,733 shares, increasing direct ownership by 36% to 62,598 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 96d
  Chief Development Officer Daniels Eric Joseph covered exercise/tax liability with 238 shares, decreasing direct ownership by 0.90% to 26,137 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 96d
  President and CEO Strem Brian M. covered exercise/tax liability with 238 shares, decreasing direct ownership by 0.52% to 45,865 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 433d
  CFO Tosca Melissa was granted 7,772 shares, increasing direct ownership by 57% to 21,371 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 433d
  Chief Development Officer Daniels Eric Joseph was granted 7,772 shares, increasing direct ownership by 42% to 26,375 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 433d
  President and CEO Strem Brian M. was granted 15,941 shares, increasing direct ownership by 53% to 46,103 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 433d
  SEC Form 4 filed by Director Shapiro Aron

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 433d
  SEC Form 4 filed by Director Parsons Erin

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 433d
  SEC Form 4 filed by Director Hollander David

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 433d
  SEC Form 4 filed by Director Tyle Praveen

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 433d
  SEC Form 4 filed by Director Stengone Carmine N.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 433d
  SEC Form 4 filed by Director Walters-Hoffert Lisa

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 706d
  President and CEO Strem Brian M. was granted 15,629 shares, increasing direct ownership by 108% to 30,160 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 706d
  CFO Tosca Melissa was granted 7,620 shares, increasing direct ownership by 192% to 11,599 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 706d
  Chief Development Officer Daniels Eric Joseph was granted 7,355 shares, increasing direct ownership by 66% to 18,577 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 706d
  SEC Form 4 filed by Director Stengone Carmine N.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 706d
  SEC Form 4 filed by Director Parsons Erin

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 706d
  SEC Form 4 filed by Director Shapiro Aron

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 706d
  SEC Form 4 filed by Director Hollander David

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 706d
  SEC Form 4 filed by Director Walters-Hoffert Lisa

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 706d
  SEC Form 4 filed by Director Tyle Praveen

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 980d
  Tosca Melissa was granted 30,000 shares, increasing direct ownership by 612% to 34,900 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 980d
  Daniels Eric Joseph was granted 62,500 shares, increasing direct ownership by 242% to 88,338 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 980d
  Strem Brian M. was granted 75,000 shares, increasing direct ownership by 261% to 103,783 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 980d
  SEC Form 4 filed by Tyle Praveen

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 980d
  SEC Form 4 filed by Shapiro Aron

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 980d
  SEC Form 4 filed by Stengone Carmine N.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 980d
  SEC Form 4 filed by Hollander David

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 980d
  SEC Form 4 filed by Gayron Kenneth L

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 980d
  SEC Form 4 filed by Parsons Erin

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1190d
  SEC Form 4 filed by Parsons Erin

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1190d
  SEC Form 4: Tosca Melissa was granted 2,400 shares, increasing direct ownership by 48% to 7,400 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1190d
  SEC Form 4: Strem Brian M. was granted 15,600 shares, increasing direct ownership by 118% to 28,783 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1190d
  SEC Form 4: Daniels Eric Joseph was granted 15,600 shares, increasing direct ownership by 152% to 25,838 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1190d
  SEC Form 4 filed by Gayron Kenneth L

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1190d
  SEC Form 4 filed by Shapiro Aron

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1190d
  SEC Form 4 filed by Tyle Praveen

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1190d
  SEC Form 4 filed by Hollander David

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1190d
  SEC Form 4 filed by Chaney Paul G

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1323d
  SEC Form 4: Daniels Eric Joseph was granted 10,000 shares, increasing direct ownership by 4,202% to 10,238 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1323d
  SEC Form 4: Tosca Melissa was granted 2,500 shares

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1323d
  SEC Form 4: Strem Brian M. was granted 12,500 shares, increasing direct ownership by 1,830% to 13,183 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1587d
  SEC Form 4 filed by Romano Sarah

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1587d
  SEC Form 4 filed by Tyle Praveen

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1587d
  SEC Form 4 filed by Chaney Paul G

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1587d
  SEC Form 4 filed by Gayron Kenneth L

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1587d
  SEC Form 4 filed by Parsons Erin

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1587d
  SEC Form 4 filed by Daniels Eric Joseph

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1587d
  SEC Form 4 filed by Hollander David

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1587d
  SEC Form 4 filed by Strem Brian M.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1587d
  SEC Form 4 filed by Shapiro Aron

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1615d
  SEC Form 4: Romano Sarah covered exercise/tax liability with 114 shares, decreasing direct ownership by 0.50% to 22,854 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1615d
  SEC Form 4: From Stephen covered exercise/tax liability with 326 shares, decreasing direct ownership by 0.48% to 67,693 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1644d
  SEC Form 4: From Stephen covered exercise/tax liability with 273 shares, decreasing direct ownership by 0.40% to 68,019 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1644d
  SEC Form 4: Romano Sarah covered exercise/tax liability with 91 shares, decreasing direct ownership by 0.39% to 22,968 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

Other KPRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends